Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Jun 2006):

Drug insight: Clopidogrel nonresponsiveness.

Full Abstract

Platelet reactivity to agonists and subsequent activation are important factors that affect the development of atherothrombosis and resultant ischemic events. Pharmacologic intervention with clopidogrel and aspirin during acute coronary syndromes and percutaneous coronary intervention is considered the gold standard for attenuating platelet activation and aggregation. Despite significant benefits reported with dual antiplatelet treatment in major clinical trials, the occurrence of adverse ischemic events, including stent thrombosis, remains a serious clinical problem. Nonresponsiveness, also called resistance, to current clopidogrel regimens might play a part in the occurrence of ischemic events. Various mechanisms have been implicated in nonresponsiveness to clopidogrel, including variability in intestinal absorption and hepatic conversion to the active metabolite, drug-drug interactions and receptor polymorphisms. Increased loading and maintenance doses and the use of new and more-potent P2Y12-receptor blockers might overcome the phenomenon of clopidogrel nonresponsiveness. The aim of this article is to provide a comprehensive and current review of clopidogrel response variability and nonresponsiveness.

 

Author information

Author/s: Gurbel, Paul A (PA); Tantry, Udaya S (US);

Affiliation: Sinai Center for Thrombosis Research, Baltimore, MD 21215, USA. pgurbel(-atsign-)lifebridgehealth.org

Journal and publication information

Publication Type: Journal Article; Review

Journal: Nature clinical practice. Cardiovascular medicine (Nat Clin Pract Cardiovasc Med), published in England. (Language: eng)

Reference: 2006-Jul; vol 3 (issue 7) : pp 387-95

Dates: Created 2006/06/30; Completed 2006/11/21;

PMID: 16810174, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Platelet Aggregation Inhibitors (0) ; Ticlopidine (55142-85-3) ; clopidogrel (90055-48-4)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

3/30/1989
9/29/2008
Higher Relevance Score (65)
Lower Relevance Score (50)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index